Say Hello!
Don’t be shy.

   

News

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has added a range of new solid-state capabilities to its portfolio through a new collaborative partnership with Barcelona-based Solitek. The sector-leading expertise and technology development within Solitek combines an excellent understanding...

Research published today has demonstrated the viability of 3D-printed tissue scaffolds that harmlessly degrade while promoting tissue regeneration following implantation. The scaffolds showed highly promising tissue-healing performance, including the ability to support cell migration, the ‘ingrowth’ of tissues, and revascularisation (blood vessel growth). Professor Andrew Dove, from...

BioCity Nottingham based Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co. Financial details have not been disclosed. Sygnature is a world-class provider of outsourced...

The best and brightest Life Sciences companies from across the Midlands have been shortlisted for the Medilink Midlands Business Awards 2021. This free awards ceremony will take place online, on Wednesday 30 June, from 3:00pm to 6:00pm The business awards celebrate the achievements, breakthroughs and innovations...

ARU is chosen to deliver world’s largest healthcare entrepreneurship programme Anglia Ruskin University (ARU) has been chosen as the official partner of NHS England and NHS Improvement to nurture healthcare innovators from across the country and help them gain the commercial skills, knowledge and experience to...